Facet browsing currently unavailable
Page 1 of 16534 results
Sort by: relevance publication year
Late combination of transarterial chemoembolization with apatinib and camrelizumab for unresectable hepatocellular carcinoma is superior to early combination JOURNAL ARTICLE published December 2022 in BMC Cancer Research funded by National Natural Science Foundation of China (81873917,81873917,81873917,81873917,81873917,81873917,81873917,81873917,81873917,81873917,81873917,81873917,81873917) | Science and Technology department of Yibin (Grant No.2020SF004) |
Lack of association between polymorphisms in the CYP1A2 gene and risk of cancer: evidence from meta-analyses JOURNAL ARTICLE published December 2016 in BMC Cancer |
Osteoblastic bone reaction in non-small cell lung cancer harboring epidermal growth factor receptor mutation treated with osimertinib JOURNAL ARTICLE published 6 September 2023 in BMC Cancer |
Immunohistochemical analysis of Tn antigen expression in colorectal adenocarcinoma and precursor lesions JOURNAL ARTICLE published 7 December 2022 in BMC Cancer Research funded by American Society of Colon and Rectal Surgeons (Limited Project Grant 109) |
The bone marrow aspirate and biopsy in the diagnosis of unsuspected nonhematologic malignancy: A clinical study of 19 cases JOURNAL ARTICLE published December 2005 in BMC Cancer |
Multi-region sampling with paired sample sequencing analyses reveals sub-groups of patients with novel patient-specific dysregulation in Hepatocellular Carcinoma JOURNAL ARTICLE published 3 February 2023 in BMC Cancer Research funded by Singapore National Medical Research Council (TCR/015-NCC/2016) |
Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein–Barr virus DNA level JOURNAL ARTICLE published December 2020 in BMC Cancer |
Smoking cessation and survival among people diagnosed with non-metastatic cancer JOURNAL ARTICLE published December 2020 in BMC Cancer |
Sentinel lymph node procedure in patients with recurrent vulvar squamous cell carcinoma: a proposed protocol for a multicentre observational study JOURNAL ARTICLE published December 2022 in BMC Cancer Research funded by KWF Kankerbestrijding (13292) |
Circulating proteins in response to combined-modality therapy in rectal cancer identified by antibody array screening JOURNAL ARTICLE published December 2016 in BMC Cancer Research funded by Akershus University Hospital (2011003, 2014011) | South-Eastern Norway Regional Health Authority (2013002, 2013101, 2014012-ACREDIT) |
Induction of plasminogen activator inhibitor type-1 (PAI-1) by hypoxia and irradiation in human head and neck carcinoma cell lines JOURNAL ARTICLE published December 2007 in BMC Cancer |
Genetic variation in TLR or NFkappaB pathways and the risk of breast cancer: a case-control study JOURNAL ARTICLE published December 2013 in BMC Cancer |
Decreased expression of hyaluronan synthase 1 and 2 associates with poor prognosis in cutaneous melanoma JOURNAL ARTICLE published December 2016 in BMC Cancer Research funded by The Academy of Finland (#131771) |
Differential regulation of NF-κB activation and function by topoisomerase II inhibitors JOURNAL ARTICLE published December 2006 in BMC Cancer |
The value of oral selective estrogen receptor degraders in patients with HR-positive, HER2-negative advanced breast cancer after progression on ≥ 1 line of endocrine therapy: systematic review and meta-analysis JOURNAL ARTICLE published 2 January 2024 in BMC Cancer |
SIRT7 promotes the proliferation and migration of anaplastic thyroid cancer cells by regulating the desuccinylation of KIF23 JOURNAL ARTICLE published 15 February 2024 in BMC Cancer |
Farnesoid X receptor as marker of osteotropism of breast cancers through its role in the osteomimetism of tumor cells JOURNAL ARTICLE published December 2020 in BMC Cancer |
High nuclear/cytoplasmic ratio of Cdk1 expression predicts poor prognosis in colorectal cancer patients JOURNAL ARTICLE published December 2014 in BMC Cancer |
Loss of miR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion JOURNAL ARTICLE published December 2012 in BMC Cancer |
Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib®versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation – HeiLivCa [ISRCTN24081794] JOURNAL ARTICLE published December 2008 in BMC Cancer |